Subscribe to Newsletter

Point of care testing

Outside the Lab Point of care testing

To POCT or Not to POCT?

| Michael Schubert

Many previously laboratory-based tests now have rapid and reliable POCT alternatives – and primary care providers should be encouraged to use them.

Subspecialties Microbiology and immunology

Gonorrhea: A Rising Resistance

| Suneeta Soni, Tariq Sadiq

With the increasing emergence of multidrug-resistant gonorrhoea strains, we interview two experts to discover how we can combat the issue

Diagnostics Microbiology and immunology

Out With the Old

| Luke Turner

Existing tests for rapid diagnosis of TB are costly and insufficient – but second-generation assays with improved sensitivity could be the answer

Diagnostics Liquid biopsy

A Diagnostic to Drool Over?

| Luke Turner

The use of saliva as a diagnostic fluid seems an attractive option – especially now that research reveals circulating tumor DNA in the fluid

Diagnostics Biochemistry and molecular biology

One TINY Step at a Time

| Michael Schubert

For regions with limited infrastructure, a device that can diagnose Kaposi’s sarcoma without the need for a steady power supply could be invaluable

Outside the Lab Screening and monitoring

Steps Forward in Cancer Screening

| Luke Turner

We round up the latest news in pathology and laboratory medicine with these bite-sized stories

Diagnostics Point of care testing

Smarter, Faster Sepsis Testing

| David Ludvigson

A two-stage model featuring point of care sepsis testing and follow-up lab results could improve treatment and reduce the risk of mortality

Outside the Lab Point of care testing

Catching the Bug

| Luke Turner

Cutting time to diagnosis for influenza from days to minutes can prevent unnecessary patient isolation and lost hospital bed space

Inside the Lab Clinical care

Biochip Breakthrough

| Luke Turner, Arjang Hassibi

With antimicrobial resistance an ever-increasing threat to modern medicine, a new breakthrough may rapidly identify drug-resistant microbe strains to ensure effective treatment

Outside the Lab Biochemistry and molecular biology

Pre-Empting Relapse

| Luke Turner

A new DNA test that can detect treatment-resistant mutations could prove crucial for patients with acute myeloid leukemia, providing an early indication that targeted therapeutic intervention is needed

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register